New data showing sustained complete renal response with LUPKYNIS through three years Monthly kidney function assessment no longer required after first year…
24.04.2024 - Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates In-depth analysis of VIVIAD Phase 2b results is ongoing, including pre-specified and exploratory endpoints; findings to date .
Protara Therapeutics (TARA) Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Protara Therapeutics Announces Positive Three-Month Data From TARA-002 Clinical Program In NMIBC menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Fifteen current and former state employees said they worked under a supervisor who built a culture of fear, retaliation and paranoia. Last year, she returned to lead some of those who spoke out against her.